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ditional $162,000 per QALY gained (16 quality-adjusted
minutes per flight). Sensitivity analysis of event proba-
bilities and cost inputs did not substantially change the
results. However, the cost-effectiveness of AEDs was sig-
nificantly enhanced by the inclusion of utility gain experi-
enced by passengers from increased peace of mind. While
the magnitude of this benefit is unknown, an incremental
increase of .003 in utility over the flight duration would
reduce the incremental cost-effectiveness of AEDs to less
than $50,000 per QALY gained. CONCLUSIONS: Our
model estimated that when the benefits of on-board
AEDs are limited to patients experiencing medical events,
the incremental cost-effectiveness is inferior to most rec-
ommended medical interventions. However, if passengers
gain utility from knowing an AED is on the aircraft, then
these incremental expenditures may be justified. Utility
gains from “peace of mind” may have significant impli-
cations in determining the value of health care interven-
tions. Further research should be conducted into this po-
tentially important area.
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ANALYSIS OF THE IMPACT OF ASSISTIVE 
LIVING DEVICES ON SELF-ASSESSED HEALTH 
STATUS RATING
Rodney AB, Xiao H, Robertson T
Florida A&M University, Tallahassee, FL, USA
OBJECTIVE: Persons with limitations in Activities of
Daily Living (ADLs) generally report a greater sense of
independence when they have the use of assistive devices.
Insurance companies have traditionally been reluctant to
cover the cost of such devices, considering them to be
non-essential equipment. Although the economic cost
savings associated with a decrease in the need for exter-
nal caregivers and institutionalization are calculable, the
psychological benefits arising from this greater degree of
independence seen in patients who use assistive devices
tends to be overlooked. Therefore the main objective of
this project was to determine the impact of assistive living
devices on patients self-rated health status. METHOD:
Medical Expenditure Panel Survey (MEPS) Household
Component file 1998 P2R3/P3R1 was utilized for this
project. The initial pool of 25,000 cases was narrowed
using the inclusion criteria whereby all subjects must be
65 years or older, and have coded that they possessed one
or more physical disabilities or limitations. This led to a
final sample size of 1,025. Information on demographics,
socioeconomic status and level of disability was extracted
from the database for these patients. Multiple regression
analysis was conducted with self-rating of health status
serving as the dependent variable. The primary indepen-
dent variable of interest was use or non-use of assistive
living devices. Secondary independent variables included:
marital status, sex, age, race, educational level, physical
disabilities and limitations, and social limitations. RE-
SULTS: Use of assistive devices, race, age, some forms of
physical limitations and levels of education were signifi-
cant in this model (p  0.05). Marital status and gender
proved to be insignificant factors. CONCLUSIONS: Use
of assistive devices does have an impact on the way in
which individuals with limitations and disabilities view
their health status and therefore may be important con-
tributors to their overall quality of life.
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OBJECTIVES.
 
 Positron Emission Tomography with 18F-
fluorodeoxyglucose (FDG-PET) is a new nuclear imaging
technique that can detect recurrent or metastatic thyroid
carcinomas. We conducted a systematic review to deter-
mine the diagnostic accuracy of FDG-PET in patients
with papillary and follicular thyroid carcinoma. METH-
ODS. Two unblinded reviewers independently selected,
extracted and assessed data from relevant literature. In-
cluded studies were prospective or retrospective with 10
human subjects or more that evaluated the accuracy of
FDG-PET in follicular and papillary thyroid cancer. Re-
views, case reports, editorials, letters, and comments
were excluded. The methodological quality of the in-
cluded studies was assessed by the criteria for diagnostic
tests recommended by the Cochrane Methods Group on
Screening and Diagnostic Tests. A qualitative analyse was
conducted to assess the value of FDG-PET in thyroid car-
cinoma. The rating system consisted of four levels of sci-
entific evidence (1  best; 4  worst). RESULTS. Two of
the fourteen included studies were considered of level 3
evidence. The other twelve studies provided level 4 evi-
dence. Most prevalent methodological flaws regarded va-
lidity of reference tests and blinding of test interpretation.
The overall conclusion in these studies was that FDG-
PET appeared beneficial in patients with elevated thyro-
globulin levels and negative 131I WBS. CONCLUSIONS.
In conclusion, although FDG-PET may solve clinical prob-
lems in selected patients suspected of recurrent thyroid
cancer, the present evidence does not allow for imple-
mentation of a routine diagnostic algorithm. Future stud-
ies should be designed to avoid the limitations presented
in this review.
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INCLUSION OF INDIRECT COST IN ECONOMIC 
OUTCOMES ANALYSES OF MEDICAL DEVICES: 
HOW IMPORTANT IS IT?
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OBJECTIVE: To evaluate the impact of indirect cost
(due to absence from work, disability, mortality) in eco-
nomic evaluations comparing minimally invasive proce-
